Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects

Japanese Journal of Ophthalmology

Volumn 56, Issue 4, 2012, Pages 346-353

  Kawaguchi, Ichiro ^a,b   Higashide, Tomomi ^b   Ohkubo, Shinji ^b   Kawaguchi, Chiaki ^b   Sugiyama, Kazuhisa ^b  

^a Houju Memorial Hospital   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Bilateral treatment; Intraocular pressure; Non responder; Normal subjects; Prostaglandin analogues

Indexed keywords

BIMATOPROST; LATANOPROST; TAFLUPROST; TRAVOPROST;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; EVENING DOSAGE; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AMIDES; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; CLOPROSTENOL; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; PROSTAGLANDINS F; PROSTAGLANDINS F, SYNTHETIC; TONOMETRY, OCULAR; TREATMENT OUTCOME;

EID: 84863860018     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-012-0155-2     Document Type: Article

References (21)

1. Stewart WC, Konstas AG, Nelson LA, Kruft B. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Ophthalmology. 2008;115:1117-22.
2. Cheng JW, Cai JP, Wei RL. Meta-analysis of medical intervention for normal tension glaucoma. Ophthalmology. 2009;116:1243-9.
3. van der Valk R, Webers CA, Lumley T, Hendrikse F, Prins MH, Schouten JS. A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure. J Clin Epidemiol. 2009;62:1279-83.
4. Rossetti L, Gandolfi S, Traverso C, Montanari P, Uva M, Manni G, et al. An evaluation of the rate of nonresponders to latanoprost therapy. J Glaucoma. 2006;15:238-43.
5. Ikeda Y, Mori K, Ishibashi T, Naruse S, Nakajima N, Kinoshita S. Latanoprost nonresponders with open-angle glaucoma in the Japanese population. Jpn J Ophthalmol. 2006;50:153-7.
6. Gandolfi SA, Cimino L. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmology. 2003;110:609-14. (Pubitemid 36262750)
7. Kaback M, Geanon J, Katz G, Ripkin D. START Study Group. Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost. Curr Med Res Opin. 2004;20:1341-5. (Pubitemid 39361336)
8. Sit AJ, Liu JH, Weinreb RN. Asymmetry of right versus left intraocular pressures over 24 hours in glaucoma patients. Ophthalmology. 2006;113:425-30.
9. Takahashi M, Higashide T, Sakurai M, Sugiyama K. Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects. J Glaucoma. 2008;17:169-74. (Pubitemid 351543539)
10. Realini T, Vickers WR. Symmetry of fellow-eye intraocular pressure responses to topical glaucoma medications. Ophthalmology. 2005;112:599-602. (Pubitemid 41108859)
11. Lim KS, Nau CB, O'Byrne MM, Hodge DO, Toris CB, McLaren JW, et al. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. Ophthalmology. 2008;115:790-5.
12. Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD. A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normaltension glaucoma. Adv Ther. 2006;23:385-94. (Pubitemid 44409544)
13. Casson RJ, Liu L, Graham SL, Morgan WH, Grigg JR, Galanopoulos A, et al. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study. J Glaucoma. 2009;18:582-8.
14. Ota T, Aihara M, Narumiya S, Araie M. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci. 2005;46:4159-63. (Pubitemid 44264618)
15. Cantor LB, Hoop J, Wudunn D, Yung CW, Catoira Y, Valluri S, et al. Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract. Br J Ophthalmol. 2007;91:629-32. (Pubitemid 46716532)
16. Liang Y, Woodward DF, Guzman VM, Li C, Scott DF, Wang JW, et al. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br J Pharmacol. 2008;154:1079-93. (Pubitemid 351915050)
17. Alm A, Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology. 1995;102:1743-52. (Pubitemid 26004426)
18. Wakabayashi Y, Higashide T, Sugiyama K. Improved prediction of fellow-eye response in one-eye trials using multiple intraocular pressure measurements. Jpn J Ophthalmol. 2011;55:480-5.
19. Pandav SS, Sharma A, Gupta A, Sharma SK, Gupta A, Patnaik B. Reliability of ProTon and Goldmann applanation tonometers in normal and postkeratoplasty eyes. Ophthalmology. 2002;109:979-84. (Pubitemid 34465235)
20. Frenkel RE, Noecker RJ, Craven ER. Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%. Curr Med Res Opin. 2008;24:919-23. (Pubitemid 351579150)
21. Mochizuki H, Itakura H, Yokoyama T, Takamatsu M, Kiuchi Y. Twenty-four-hour ocular hypotensive effects of 0.0015% tafluprost and 0.005% latanoprost in healthy subjects. Jpn J Ophthalmol. 2010;54:286-90.